. 2020; 48(7): 631-634 | DOI: 10.5543/tkda.2020.64072 | |||
COVID-19 ve RAAS blokerleri: Aliskiren uygun bir seçenek olabilir mi?Selçuk Şen, Ali Yağız Üresinİstanbul Üniversitesi, İstanbul Tıp Fakültesi, Tıbbi Farmakoloji Anabilim Dalı, Klinik Farmakoloji Bilim Dalı, İstanbul, TürkiyeAnahtar Kelimeler: COVID-19, ACE inhibitorü, anjiotensin reseptör blokeri, direkt renin inhibitörü, aliskiren COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?Selçuk Şen, Ali Yağız ÜresinDepartment of Medical Pharmacology, Division of Clinical Pharmacology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, TurkeyKeywords: COVID-19, ACE inhibitor, angiotensin receptor blocker, direct renin inhibitor, aliskiren Selçuk Şen, Ali Yağız Üresin. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?. . 2020; 48(7): 631-634 Sorumlu Yazar: Selçuk Şen, Türkiye |
|